Cite
HARVARD Citation
Harris, R. et al. (2020). Protocol for a multinational risk-stratified randomised controlled trial in paediatric Crohn's disease: methotrexate versus azathioprine or adalimumab for maintaining remission in patients at low or high risk for aggressive disease course. BMJ open. 10 (7), p. . [Online].